Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05782140 · ClinicalTrials.gov registry record
ALgorithms Adapted From Remote Monitoring
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 56
- Enrollment target
NCT05782140: Clinical Trial study, sponsored by Mayo Clinic.
NCT05782140 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05782140 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 56 participants
- Enrollment target
Study Summary
Through the aid of remote monitoring and early symptom detection, a patient's response to stress and normalization to their individual baseline can better contribute towards algorithms which are predictive of clinical decline.
Primary Outcome
Determine the feasibility of remote monitoring for preoperative assessment and postoperative follow up by evaluation of rate of compliance of physiological monitoring data and patinet recorded logs.
Interventions
- DEVICE Mayo Clinic Watch Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2025-02-25 |
Why NCT05782140 stopped before completion
NCT05782140 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Mayo Clinic Watch Device is the first listed.
NCT05782140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05782140 about?
NCT05782140 is a clinical study titled "ALgorithms Adapted From Remote Monitoring". Through the aid of remote monitoring and early symptom detection, a patient's response to stress and normalization to their individual baseline can better contribute towards algorithms which are predictive of clinical decline.
What is the current status of trial NCT05782140?
This trial is currently terminated. The enrollment target is 56 participants. The study started on 2023-02-20. Estimated completion is 2025-02-25.
What interventions are being tested in trial NCT05782140?
The interventions under investigation include: Mayo Clinic Watch Device (DEVICE).
Who is sponsoring clinical trial NCT05782140?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI